Announce Date | 11/21/2024 |
EPS Normalized Actual | $2.5 (Beat by $0.15) |
EPS GAAP Actual | $2.5 (Beat by $0.15) |
Revenue Actual | $5.632B |
Revenue Surprise | Beat by $5632M |
Announce Date | 10/30/2024 (Pre-Market) |
EPS Normalized Estimate | $2.71897 |
EPS GAAP Estimate | $2.71897 |
Revenue Estimate | $3.374984456B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2027 | 26 | 24.75 | 25.58912 | 26.68574 | 11 |
Jul 2026 | 13.92567 | 46.2 | 12.44149 | 17.14 | 8 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (Apr 2022) | 6.34 | 6.34 | 5.632B | 25.91% | 5632M |
FQ1 2022 (Jan 2022) | 0.35 | 0.35 | 2.673B | 41.04% | 2673M |
FQ4 2021 (Oct 2021) | 0.84 | 0.84 | 2.007B | 34.08% | 2007M |
FQ3 2021 (Jul 2021) | 1.39 | 1.39 | 2.561B | 29.09% | 2561M |
FQ2 2021 (Apr 2021) | 5.36 | 5.36 | 4.173B | 28.06% | 4173M |
FQ1 2021 (Jan 2021) | 0.07 | 0.07 | 1.576B | -7.61% | 1576M |
FQ4 2020 (Oct 2020) | 0.75 | 0.75 | 1.323B | 11.94% | 1323M |
FQ3 2020 (Jul 2020) | 1.7 | 1.7 | 1.816B | 45.26% | 1816M |
FQ4 Announce Date
10/30/2024 (Pre-Market)
Consensus EPS Estimates
2.71897
Consensus Revenue Estimates
3.374984456B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 13.35013 | -- | 13.07537 | 13.77089 | 5 |
FQ1 2027 (Jan 2027) | 4.11368 | -- | 4.02902 | 4.24333 | 5 |
FQ4 2026 (Oct 2026) | 3.23288 | -- | 3.16634 | 3.33477 | 5 |
FQ3 2026 (Jul 2026) | 2.53138 | -- | 2.51232 | 2.57564 | 6 |
FQ2 2026 (Apr 2026) | 12.14841 | -- | 12.05695 | 12.3608 | 6 |
FQ1 2026 (Jan 2026) | 3.08401 | -- | 3.03166 | 3.16019 | 9 |
FQ4 2025 (Oct 2025) | 3.00265 | -- | 2.98004 | 3.05514 | 10 |
FQ3 2025 (Jul 2025) | 2.29706 | -- | 2.27977 | 2.33722 | 10 |
FQ2 2025 (Apr 2025) | 10.92531 | -- | 10.84306 | 11.11631 | 10 |
FQ1 2025 (Jan 2025) | 2.79995 | -- | 2.75242 | 2.86911 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 8.98B | -- | 8.84B | 9.2B | 5 |
FQ1 2027 (Jan 2027) | 4.92B | -- | 4.84B | 5.04B | 5 |
FQ4 2026 (Oct 2026) | 4.09B | -- | 4.02B | 4.19B | 9 |
FQ3 2026 (Jul 2026) | 3.9B | -- | 3.88B | 3.95B | 7 |
FQ2 2026 (Apr 2026) | 8.03B | -- | 7.98B | 8.14B | 8 |
FQ1 2026 (Jan 2026) | 4.26B | -- | 4.21B | 4.35B | 4 |
FQ4 2025 (Oct 2025) | 3.78B | -- | 3.75B | 3.83B | 6 |
FQ3 2025 (Jul 2025) | 3.51B | -- | 3.49B | 3.55B | 9 |
FQ2 2025 (Apr 2025) | 7.32B | -- | 7.28B | 7.42B | 6 |
FQ1 2025 (Jan 2025) | 3.82B | -- | 3.77B | 3.89B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | 6.34 | 6.34 | 100% | |
FQ1 2022 (Jan 2022) | 0.35 | 0.35 | 100% | |
FQ4 2021 (Oct 2021) | 0.84 | 0.84 | 100% | |
FQ3 2021 (Jul 2021) | 1.39 | 1.39 | 100% | |
FQ2 2021 (Apr 2021) | 5.36 | 5.36 | 100% | |
FQ1 2021 (Jan 2021) | 0.07 | 0.07 | 100% | |
FQ4 2020 (Oct 2020) | 0.75 | 0.75 | 100% | |
FQ3 2020 (Jul 2020) | 1.7 | 1.7 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (Apr 2022) | $0B | $5.63B | $5632M | 100% |
FQ1 2022 (Jan 2022) | $0B | $2.67B | $2673M | 100% |
FQ4 2021 (Oct 2021) | $0B | $2.01B | $2007M | 100% |
FQ3 2021 (Jul 2021) | $0B | $2.56B | $2561M | 100% |
FQ2 2021 (Apr 2021) | $0B | $4.17B | $4173M | 100% |
FQ1 2021 (Jan 2021) | $0B | $1.58B | $1576M | 100% |
FQ4 2020 (Oct 2020) | $0B | $1.32B | $1323M | 100% |
FQ3 2020 (Jul 2020) | $0B | $1.82B | $1816M | 100% |